By Our Staff Writer
CureMeAbroad, an India-based AI-led medical tourism platform, announced major international expansion, with plans to set up experience centres across the US, the UK and Australia.
While the startup has signed a memorandum of understanding (MoU) to set up a network of experience centres in Australia, with its first centre going live in Brisbane this week, it disclosed plans to establish more than 40 centres across Australia, the US and the UK.
It also plans to widen its destination network, with Mexico, Vietnam and Indonesia in the next phase.
The startup said it is also expanding its treatment offerings to include oncology, neurology, orthopaedics, surrogacy and IVF.
“Patients considering treatment abroad often want to sit across a table from a real person before they commit, and that matters even more as we move into areas like oncology, neurology, surrogacy and IVF,” said Aditya Oza, Co-founder and CEO, CureMeAbroad,Commenting on the expansion.
The company’s centres will provide patients with in-person consultations and on-site doctor teleconsultations to help them explore treatment options abroad.
Through its digital platform, CureMeAbroad connects patients with more than 400 hospital partners across Turkey, Thailand, India, Mexico, Georgia and other destinations.
Patients can also access its AI cost estimator and journey planner, with coordinators providing support.
The venture said Australia is among its key source markets, alongside the US, UK, Germany and the GCC.
The company is a signatory to the UN Global Compact and holds Global Healthcare Accreditation’s medical travel facilitator certification, with registered offices in India and the US.
